Cargando…

A Novel Clinical Prognostic Model for Breast Cancer Patients with Malignant Pleural Effusion: Avoiding Chemotherapy in Low-Risk Groups?

PURPOSE: Malignant pleural effusion (MPE) is a severe complication in patients with advanced cancer that is associated with a poor prognosis. Breast cancer is the second leading cause of MPE after lung cancer. We therefore aim to describe clinical characteristics of the patients with MPE combined wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yichen, Zhou, Tao, Zhao, Shanshan, Li, Ning, Sun, Siwen, Li, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184893/ https://www.ncbi.nlm.nih.gov/pubmed/37197007 http://dx.doi.org/10.2147/CMAR.S409918

Ejemplares similares

Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma‐induced malignant pleural effusion
por: Tao, Hong, et al.
Publicado: (2018)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion
por: Shan, Yi, et al.
Publicado: (2017)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Important prognostic factors for survival in patients with malignant pleural effusion
por: Zamboni, Mauro Musa, et al.
Publicado: (2015)

Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion
por: Drevet, Gabrielle, et al.
Publicado: (2020)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Prognostic Factors of 30-day Survival of Patients with Malignant Pleural Effusion
por: Amin, Zulkifli, et al.
Publicado: (2017)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Primary malignant myelomatous pleural effusion
por: Mangla, Ankit, et al.
Publicado: (2016)

Pleural procedures in the management of malignant effusions
por: Ferreiro, Lucía, et al.
Publicado: (2017)

Management of Septated Malignant Pleural Effusions
por: Banka, Radhika, et al.
Publicado: (2018)

Malignant Pleural Effusion: Diagnosis and Management
por: Ferreiro, Lucía, et al.
Publicado: (2020)

Surgical treatment in malignant pleural effusion
por: Karadayı, Şule, et al.
Publicado: (2021)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023)

Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
por: Shi, Xin‐Yu, et al.
Publicado: (2019)

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)

Implantation of permanent pleural catheter for palliation of malignant pleural effusion
por: Meier, Michelle, et al.
Publicado: (2016)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
por: Báez-Saldaña, Renata, et al.
Publicado: (2017)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Indwelling pleural catheters for malignant pleural effusion – Are we ready?
por: Patel, Dharmesh, et al.
Publicado: (2022)

Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion
por: Li, Zihui, et al.
Publicado: (2023)

Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion
por: Tian, Tian, et al.
Publicado: (2019)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Prognostic factors of recurrence of malignant pleural effusion: what is the role of neoplasia progression?
por: Abrão, Fernando Conrado, et al.
Publicado: (2020)

Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model
por: Zhang, Xin, et al.
Publicado: (2021)

Diagnostic value of medical thoracoscopy in malignant pleural effusion
por: Wu, Yan-Bing, et al.
Publicado: (2017)

The diagnostic utility of pleural markers for tuberculosis pleural effusion
por: Zhang, Man, et al.
Publicado: (2020)

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion
por: Li, Shi, et al.
Publicado: (2015)

BCG treatment of malignant pleural effusions in the rat.
por: Pimm, M. V., et al.
Publicado: (1976)

DR-70 immunoassay and malignant pleural effusion
por: Joob, Beuy, et al.
Publicado: (2014)

Malignant pleural effusion from prostate adenocarcinoma
por: Knight, James C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0hi87ap3sv04ncf8e9k8mau1s3